Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT-G protein complex.
作者信息
Huang Sijie, Xu Peiyu, Tan Yangxia, You Chongzhao, Zhang Yumu, Jiang Yi, Xu H Eric
机构信息
The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
University of Chinese Academy of Sciences, Beijing, China.
出版信息
Cell Res. 2021 Sep;31(9):1036-1038. doi: 10.1038/s41422-021-00527-4. Epub 2021 Jul 8.
Abstract
摘要
相似文献
1
Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT-G protein complex.
Cell Res. 2021 Sep;31(9):1036-1038. doi: 10.1038/s41422-021-00527-4. Epub 2021 Jul 8.
2
The selective 5-HT receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headache.
Br J Pharmacol. 2022 Feb;179(3):358-370. doi: 10.1111/bph.15699. Epub 2021 Nov 16.
3
Characterization of binding, functional activity, and contractile responses of the selective 5-HT receptor agonist lasmiditan.
Br J Pharmacol. 2019 Dec;176(24):4681-4695. doi: 10.1111/bph.14832. Epub 2019 Nov 7.
4
The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.
Expert Opin Pharmacother. 2017 Sep;18(13):1409-1415. doi: 10.1080/14656566.2017.1361406. Epub 2017 Aug 10.
5
Targeting the 5-HT and 5-HT receptors for acute migraine treatment.
Prog Brain Res. 2020;255:99-121. doi: 10.1016/bs.pbr.2020.05.010. Epub 2020 Jun 12.
6
Lasmiditan for the acute treatment of migraine.
Pain Manag. 2021 Sep;11(5):437-449. doi: 10.2217/pmt-2021-0002. Epub 2021 Apr 12.
7
Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):241-9. doi: 10.2174/187152412803760627.
8
Lasmiditan for acute treatment of migraine.
Drugs Today (Barc). 2021 Feb;57(2):89-100. doi: 10.1358/dot.2021.57.2.3238326.
9
5-HT1F agonists.
Handb Clin Neurol. 2024;199:43-50. doi: 10.1016/B978-0-12-823357-3.00032-X.
10
Lasmiditan: First Approval.
Drugs. 2019 Dec;79(18):1989-1996. doi: 10.1007/s40265-019-01225-7.
引用本文的文献
1
G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.
Int J Mol Sci. 2024 Jun 22;25(13):6876. doi: 10.3390/ijms25136876.
2
Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs.
Adv Sci (Weinh). 2024 Jun;11(23):e2310120. doi: 10.1002/advs.202310120. Epub 2024 Apr 22.
3
Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HTR and 5-HTR.
Sci Adv. 2024 Apr 19;10(16):eadk4855. doi: 10.1126/sciadv.adk4855. Epub 2024 Apr 17.
4
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.
Signal Transduct Target Ther. 2024 Apr 10;9(1):88. doi: 10.1038/s41392-024-01803-6.
5
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.
Molecules. 2024 Feb 22;29(5):964. doi: 10.3390/molecules29050964.
6
Whether Weather Matters with Migraine.
Curr Pain Headache Rep. 2024 Apr;28(4):181-187. doi: 10.1007/s11916-024-01216-8. Epub 2024 Feb 15.
7
Structural Insights into the Unexpected Agonism of Tetracyclic Antidepressants at Serotonin Receptors 5-HT1eR and 5-HT1FR.
bioRxiv. 2023 Oct 7:2023.10.05.561100. doi: 10.1101/2023.10.05.561100.
8
Structural studies of serotonin receptor family.
BMB Rep. 2023 Oct;56(10):527-536. doi: 10.5483/BMBRep.2023-0147.
9
Structural genomics of the human dopamine receptor system.
Cell Res. 2023 Aug;33(8):604-616. doi: 10.1038/s41422-023-00808-0. Epub 2023 May 23.
10
Structural and functional imaging of brains.
Sci China Chem. 2023;66(2):324-366. doi: 10.1007/s11426-022-1408-5. Epub 2022 Dec 9.
Zotero 插件